On July 11, 2012, Merus Labs International Inc. acquired Emselex®/Enablex®. Stewart Muglich and Victor Dudas of our Corporate Finance & Securities Group handled the debt facility between Merus and PDL BioPharma Inc., a company that supports the healthcare industry with creative financing solutions, assisted by Amaan Gangji and Kevin MacDonald. The transaction involved counsel from Toronto, New York, Switzerland, the Netherlands and Luxembourg.
Related Content
Employee Ownership Trusts: An Introduction for Business Owners
As discussed in our prior article on Employee Ownership Trusts, Canadian business owners report that finding a buyer is a significant obstacle to succession planning. ... Continued
Marion Allan to present at the CBABC Ninth Annual Conference
Marion Allan will be presenting on the subject of elder law for everyone at the Canadian Bar Association BC Branch’s Ninth Annual Conference taking place ... Continued
Upcoming Webinar on Estate Litigation Fundamentals – October 1, 2021
Legal professionals interested in the area of estate litigation are invited to join this free one-hour crash course exploring the unique opportunities, challenges, and approaches ... Continued